Mycobacterium tuberculosis antigens

Subscribe to Selected New Research on Mycobacterium tuberculosis antigens

46 relevant articles (2 outcomes, 3 trials/studies) found for this Bio-Agent

Description: contains 144 amino acids; MW 16.277 kDa; 16 kDa protein was previously referred to as 14 kDa protein; aa sequence given in first source

Also Known As:

14K antigen, Mycobacterium tuberculosis; 16 kDa alpha-crystallin antigen, Mycobacterium tuberculosis; 16K antigen, M. tuberculosis; 16K protein, M. tuberculosis; MT 14 k antigen; Mycobacterium tuberculosis 14K antigen

Relationship Network

Bio-Agent Context: Research Results

Biological Factors: 871

Antigens: 93242

Bacterial Antigens: 405

Mycobacterium tuberculosis antigens: 46

Experts

1.	Campos-Neto, A: 1 article (07/2008)
2.	Rodrigues, V: 1 article (07/2008)
3.	Pollock, N: 1 article (07/2008)
4.	Napolitano, D R: 1 article (07/2008)
5.	Kashino, S S: 1 article (07/2008)
6.	Ranganathan, Uma Devi: 1 article (04/2008)
7.	Bethunaickan, Ramalingam: 1 article (04/2008)
8.	Raja, Alamelu: 1 article (04/2008)
9.	Selvaraj, P: 1 article (11/2007)
10.	Jawahar, M S: 1 article (11/2007)

Related Diseases

1.	Pulmonary Tuberculosis (Phthisis) 01/01/1991 - "Study of immunologic reactivity in patients with disseminated pulmonary tuberculosis has demonstrated that 80% of patients have sensitization to Mycobacterium tuberculosis antigens, in addition to that to bacterial flora (Streptococcus, Staphylococcus, Pneumococcus)" 11/01/1998 - "Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis." 04/01/1995 - "Antibody response to Mycobacterium tuberculosis antigens in children with pulmonary tuberculosis and in BCG vaccinated non tuberculous pediatric patients." 04/01/1994 - "Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts." 08/01/1961 - "Serodiagnosis of pulmonary tuberculosis by means of Mycobacterium tuberculosis antigens.]" Order ALL the reference details at left...
2.	Infection 12/01/2006 - "a hypersensivity reaction to Mycobacterium tuberculosis antigens rele- ased from a distant focus of infection without promoting disea- se" 01/01/2000 - "Individuals sensitised to Mycobacterium tuberculosis antigens by infection, vaccination or Mantoux test generate specific memory cells" 02/01/2006 - "Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens." 10/01/2005 - "The relationship between specific antibody profiles and tuberculosis (TB) state was investigated by measuring serum antibody levels to six Mycobacterium tuberculosis antigens in human subjects grouped into four diagnostic categories: active disease, inactive (past) tuberculosis, latent infection without radiographic chest abnormalities, and infection free" 05/01/2005 - "OBJECTIVE: To study the effects and mechanisms of DNA vaccines encoding Mycobacterium tuberculosis antigens on murine Mycobacterium tuberculosis infection" Order ALL the reference details at left...
3.	Tuberculosis 07/01/2008 - "Here, we introduce an innovative approach to directly identify Mycobacterium tuberculosis antigens produced in vivo in humans with tuberculosis" 01/01/2006 - "In this review of advances in diagnosis, we focus on strengths and limitations of newer tests that are available for the diagnosis of latent and active tuberculosis and rapid detection of drug resistance, specifically, tests that measure release of IFN-gamma in response to stimulation by Mycobacterium tuberculosis antigens, nucleic acid amplification for identification of M" 10/01/2005 - "Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia." 04/01/2003 - "The search to identify Mycobacterium tuberculosis antigens capable of conferring protective immunity against tuberculosis has received a boost owing to the resurgence of tuberculosis over the past two decades" 08/15/1998 - "Evaluating human immune response to defined Mycobacterium tuberculosis antigens in patients with different clinical forms of tuberculosis may help in elucidating pathogenesis and in vaccine development" Order ALL the reference details at left...
4.	Meningeal Tuberculosis (Tuberculous Meningitis) 10/01/1996 - "Identification of antibody responses to Mycobacterium tuberculosis antigens in the CSF of tuberculous meningitis patients by Western blotting." 09/01/2002 - "Antibodies against Mycobacterium tuberculosis antigens were detected by enzyme-linked immunosorbent assay in cerebrospinal fluid (CSF) samples obtained from 442 patients with tuberculous meningitis (TBM) and 102 control patients" Order ALL the reference details at left...
5.	Sarcoidosis (Schaumann Disease) 01/01/1996 - "Cross-reactive and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: a major clue to the etiology of sarcoidosis." 01/01/1997 - "Antibodies to Mycobacterium tuberculosis antigens H37Rv and reverse strains previously isolated from patients with sarcoidosis with granular isolates were determined in 50 patients with sarcoidosis (including 16 patients isolating granular types) and 56 patients with tuberculosis, by using ELISA and immunoblotting" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Mitogens
2.	HLA-DR Antigens (HLA-DR)
3.	Antibodies
4.	DNA Vaccines
5.	Interferon Type II (Interferon, gamma)
6.	Antigens
7.	Tuberculin (PPD)
8.	alpha-Crystallins (alpha-Crystallin)
9.	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)
10.	Proteins (Proteins, Gene)

Best Treatments:
Research Summary Report
on Pulmonary Tuberculosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 184 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>